
GENOMIC VISION Stock Bullish Momentum With A 28% Rise In The Last 21 Sessions
Genomic Vision (CAC 40: GV.PA), a leading French molecular diagnostics and technology company, experienced an exceptional surge of 28.21% over 21 sessions, tracking an upward trend seen by the CAC 40 index, which increased by 0.72% to EUR7,322.04. From an earnings per share perspective, Genomic Vision reported trailing twelve month EPS of EUR-0.11. Trading Volume…